创始人直播狂吸金，吴晓波也入局！3000万瓶贵妇精油，撑起IPO？

Core Viewpoint - The article discusses the IPO of Shanghai Linqingxuan Biotechnology Co., Ltd., highlighting its high-end positioning in the skincare market and the success of its flagship product, Camellia Oil, which has achieved significant sales and profitability growth since its launch [1][2][3]. Group 1: Company Overview - Linqingxuan was founded in 2003, launching its flagship brand in 2004 and opening its first store in 2008. The company officially introduced its core product, Camellia Oil, in 2014, targeting the facial oil segment [4]. - The market for facial oils in China has grown from 900 million yuan in 2019 to an expected 5.3 billion yuan by 2024, with a compound annual growth rate (CAGR) of 42.8% [4]. Group 2: Financial Performance - Revenue increased from 691 million yuan in 2022 to 805 million yuan in 2023, and is projected to reach 1.21 billion yuan in 2024, with a CAGR of 32.3% [7]. - The company turned a profit from a loss of 5.93 million yuan in 2022 to a net profit of 85 million yuan in 2023, and further to 187 million yuan in 2024 [8]. - Gross margins have improved from 78.0% in 2022 to 82.5% in 2024 [9]. Group 3: Product Strategy - The company focuses on a single flagship product, Camellia Oil, which has maintained the top position in the facial oil market for 11 consecutive years and is the only product in this category to exceed 100 million yuan in retail sales for eight years [6]. - The product pricing strategy ranges from 200 yuan to 800 yuan, with premium products priced as high as 1,880 yuan for a 50ml cream [5]. Group 4: Marketing and Sales Channels - Linqingxuan has invested 760 million yuan in marketing over three years, although it faced penalties for false advertising [11][13]. - The company has expanded its retail presence to 506 stores by the end of 2024, with over 95% located in shopping malls [18]. - Online sales have surged, with revenue from online channels increasing from 312 million yuan in 2022 to 714 million yuan in 2024, surpassing offline sales for the first time [20]. Group 5: Investment and Valuation - The company has attracted significant investment from notable firms, completing multiple funding rounds and achieving a pre-IPO valuation of approximately 3.84 billion yuan [26]. - Comparatively, Linqingxuan's revenue of 1.21 billion yuan in 2024 is smaller than that of other listed beauty companies, raising questions about its ability to meet IPO valuation expectations [27].